General Atlantic Portfolio
Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.
Third Harmonic Bio ×
Third Harmonic Bio is a clinical stage biotechnology company developing an oral KIT inhibitor therapy for allergic autoimmune disorders.